Chronic exposure of NG108-15 cells to inhibitory acting drugs reduces stimulatory prostaglandin E1 receptor number

European Journal of Pharmacology

Volumn 302, Issue 1-3, 1996, Pages 199-205

  Ammer, Hermann ^a   Schulz, Rüdiger ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Adenylate cyclase; Muscarinic M4 receptor; Prostaglandin E1 receptor; Receptor cross talk; (2B) Adrenoceptor; Opioid receptor

Indexed keywords

ADENYLATE CYCLASE; ALPHA 2B ADRENERGIC RECEPTOR; CLONIDINE; ENKEPHALIN[2 DEXTRO ALANINE 5 DEXTRO LEUCINE]; GUANINE NUCLEOTIDE BINDING PROTEIN; MORPHINE; MUSCARINIC M4 RECEPTOR; OXOTREMORINE; PERTUSSIS TOXIN; PROSTAGLANDIN E1; PROSTAGLANDIN RECEPTOR; SIGMA OPIATE RECEPTOR; ADENYLATE CYCLASE TOXIN; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; BORDETELLA VIRULENCE FACTOR; DELTA OPIATE RECEPTOR; ENKEPHALIN[2 ALANINE 5 LEUCINE]; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); MUSCARINIC AGENT; NALOXONE; NARCOTIC ANTAGONIST; PROSTAGLANDIN E RECEPTOR;

ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG BINDING SITE; DRUG DEPENDENCE; ENZYME INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; RECEPTOR AFFINITY; RECEPTOR BLOCKING; RECEPTOR DENSITY; REGULATORY MECHANISM; ANIMAL; BINDING COMPETITION; CATTLE; DRUG EFFECT; GLIOMA; HYBRID CELL; METABOLISM; NEUROBLASTOMA;

ADENYLATE CYCLASE; ADENYLATE CYCLASE TOXIN; ADRENERGIC ALPHA-AGONISTS; ALPROSTADIL; ANIMALS; BINDING, COMPETITIVE; CATTLE; CLONIDINE; ENKEPHALIN, LEUCINE-2-ALANINE; GLIOMA; GTP-BINDING PROTEINS; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); HUMANS; HYBRID CELLS; MUSCARINIC AGONISTS; NALOXONE; NARCOTIC ANTAGONISTS; NEUROBLASTOMA; OXOTREMORINE; PERTUSSIS TOXIN; RECEPTORS, OPIOID, DELTA; RECEPTORS, PROSTAGLANDIN E; VIRULENCE FACTORS, BORDETELLA;

EID: 0029658969     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(96)00082-9     Document Type: Article

References (31)

1. S, in wild type and transfected neuroblastoma-glioma hybrid NG 108-15 cells, Biochem. Soc. Trans. 21, 432.
2. S) during prolonged exposure of neuroblastoma × glioma cells to prostanoid agonists. Biochem. J. 285, 529.
3. S is enhanced in neuroblastoma × glioma (NG 108-15) hybrid cells chronically exposed to an opioid, Mol. Pharmacol. 43, 556.
4. 1 receptor system in neuroblastoma × glioma (NG 108-15) hybrid cells, J. Neurochem. 64, 2449.
5. Boyd, R.S., L.E. Donnelly and J. MacDermot, 1992, Opiate-dependent changes in the sensitivity of adenylate cyclase to stimulatory agonists and 5′-guanylylimidodiphosphate are independent of G protein abundance and eukaryotic ADP-ribosyltransferase activity in NG 108-15 cells, J. Neurochem. 58, 688.
6. DeBlasi, A., K. O'Reilly and H.J. Motulsky, 1989, Calculating receptor number from binding experiments using same compound as radioligand and competitor. Trends Pharmacol. Sci. 10, 227.
7. Sα activity and abundance, Biochem. J. 288, 331.
8. Fishman, P.H. and J.P.M. Finberg, 1987, Effect of the tricyclic antidepressant desipramine on β-adrenergic receptors in cultured rat glioma C6 cells, J. Neurochem. 49, 282.
9. Gilman, A.G., 1987, G proteins: transducers of receptor generated signals, Annu Rev. Biochem. 56, 615.
10. 2-adrenergic, muscarinic, and opiate receptors, Mol. Pharmacol. 43, 434.
11. 2-adrenergic receptors. J. Biol. Chem. 266, 11915.
12. 1-adrenergic receptor mRNA and ligand binding by antidepressant treatments and norepinephrine depletion in rat frontal cortex, J. Neurochem. 60, 1335.
13. Sα-mediated responses that accompany homologous or heterologous desensitization in two related somatic hybrids. Br. J. Pharmacol. 99, 309.
14. Kurose, H., T. Katada, T. Amano and M. Ui, 1983, Specific uncoupling by islet-activating protein, pertussis toxin, of negative signal transduction via alpha-adrenergic, cholinergic, and opiate receptors in neuroblastoma × glioma hybrid cells, J. Biol. Chem. 258, 4870.
15. Law, P.Y., D.S. Hom and H.H. Loh, 1983, Opiate regulation of adenosine 3′:5′-cyclic monophosphate level in neuroblastoma × glioma NG 108-15 hybrid cells: relationship between receptor occupancy and effect. Mol. Pharmacol. 23, 26.
16. 2-adrenergic receptor agonists in NG 108-15 cells, FASEB J. 2, 52.
17. i2, FEBS Lett. 269, 430.
18. 1 receptors, and adenylate cyclase activity of neuroblastoma × glioma hybrid cells, Mol. Pharmacol. 22, 360.
19. i2, Biochem. J. 267, 391.
20. Milligan, G., F.R. McKenzie, S.J. Clue, F.M. Mitchell and I. Mullaney, 1990, Guanine nucleotide binding proteins in neuroblastoma × glioma hybrid, NG 108-15, cells. Regulation of expression and function, Int. J. Biochem. 22, 701.
21. 1-adrenergic receptor mRNA levels, J. Biol. Chem. 266, 2233.
22. Nathanson, N.M., W.L. Klein and M. Nirenberg, 1978, Regulation of adenylate cyclase activity mediated by muscarinic acetylcholine receptors, Proc. Natl. Acad. Sci. USA 75, 1788.
23. 1-adrenoceptors and adenylyl cyclase activity in neonatal rat ventricular myocytes, Naunyn-Schmiedeberg's Arch. Pharmacol. 350, 267.
24. Peterson, G.L., 1983, Determination of total protein, Methods Enzymol. 91, 95.
25. Reithmann, C., B. Panzner and K. Werdan, 1992, Distinct pathways for β-adrenoceptor-induced up-regulation of muscarinic acetylcholine receptors and inhibitory G-protein α-subunits in chicken cardiomyocytes, Naunyn-Schmiedeberg's Arch. Pharmacol. 345, 530.
26. Sabol, S.L. and M. Nirenberg, 1979, Regulation of adenylate cyclase of neuroblastoma × glioma hybrid cells by alpha-adrenergic receptors II. Long lived increase of adenylyl cyclase activity mediated by alpha receptors. J. Biol. Chem. 254, 1921.
27. Scatchard, G., 1949, The attractions of proteins for small molecules and ions, Ann. N.Y Acad. Sci. 51, 660.
28. Sharma, S.K., W.A. Klee and M. Nirenberg, 1975, Dual regulation of adenylyl cyclase for narcotic dependence and tolerance, Proc. Natl. Acad. Sci. USA 72, 3092.
29. Thomas, J.M. and B.B. Hoffman, 1987, Adenylate cyclase supersensitivity: a general means of cellular adaptation to inhibitory agonists?, Trends Pharmacol. Sci. 8, 308.
30. Traber, J., R. Gullis and B. Hamprecht, 1975, Cyclic nucleotides in cell cultures of the nervous system, Fed. Proc. 41, 165.
31. Vachon, L., T. Costa and A. Herz, 1987, Opioid receptor desensitization in NG 108-15 cells: differential effects of a full and a partial agonist on opioid-dependent GTPase, Biochem. Pharmacol. 36, 2889.